Xie P, Li HL, Wei LG, Huang JM. Incidental bone metastases identified by renal dynamic scintigraphy: A case report.
Medicine (Baltimore) 2018;
97:e11483. [PMID:
30095614 PMCID:
PMC6133571 DOI:
10.1097/md.0000000000011483]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
INTRODUCTION
The Technetium-99m diethylene triamine pentaacetic acid (Tc-99m DTPA) renal dynamic scintigraphy is widely used to evaluate the split renal function and continuously demonstrate the whole urinary collecting system. Furthermore, the extrarenal uptake of technetium-99m DTPA can provide useful information for the patients.
CASE PRESENTATION
We described a 72-year-old male with a history of flank pain for 8 months and gross hematuria for 3 days. The technetium-99m diethylenetriaminepenta-acetic acid (DTPA) renal dynamic scintigraphy was performed to evaluate the split renal function. Unexpectedly, there were 2 foci of abnormal increased tracer uptake in the midline of the abdomen. The diagnosis of renal cancer was made on the basis of the imaging characteristics on the ultrasonography. The 2 foci with elevated DTPA activity were consistent with bone metastases on the images of computed tomography and magnetic resonance.
CONCLUSION
The bone metastasis is one of the etiologies of the extrarenal uptake of technetium-99m DTPA, especially for the patients with several foci.
Collapse